In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
about
Anesthetic drug development: Novel drugs and new approaches.Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats.Carboetomidate inhibits alpha4/beta2 neuronal nicotinic acetylcholine receptors at concentrations affecting animalsElectroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs.Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.Distinct Hypnotic Recoveries After Infusions of Methoxycarbonyl Etomidate and Cyclopropyl Methoxycarbonyl Metomidate: The Role of the Metaboliteγ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.Teaching an old GABA receptor new tricks.New and developing anesthesia drugs.Pharmacologic Considerations for Pediatric Sedation and Anesthesia Outside the Operating Room: A Review for Anesthesia and Non-Anesthesia Providers.Dimethoxy-etomidate: A Non-hypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.The Role of GABA Receptor Agonists in Anesthesia and Sedation.Competitive Antagonism of Anesthetic Action at the γ-Aminobutyric Acid Type A Receptor by a Novel Etomidate Analog with Low Intrinsic Efficacy.The etomidate analog ET-26 HCl retains superior myocardial performance: Comparisons with etomidate in vivo and in vitro.Etomidate derivatives: Novel pharmaceutical agents in anesthesia.[Etomidate for intravenous induction of anaesthesia].Recent advances in intravenous anesthesia and anesthetics.
P2860
Q34710067-8414E4D8-C861-4FA9-95DA-96E6FAD60B5DQ35958072-2A9E1BF3-0C7D-46FB-A20D-8D02D5CA3FFAQ36054614-3EBE8E63-CBCB-455E-8E45-CA13AC8DBE21Q36431847-500E8471-9D85-4083-978C-BA0488A5057CQ36431861-500CFD3E-D732-43BA-AAC3-F9FAE3965CC5Q36709331-11685524-6D06-4D69-8E04-CA6310B247CDQ36716721-3086387A-0630-4AEB-8960-380C6796CB94Q37985586-C0654ABE-B1AF-4A31-B235-182C9F3D7C41Q39076634-97934CB0-FDC9-4D23-8804-89C402EEE0E9Q39361432-DDC70961-CBB3-4034-A05B-E7BF5C30CDFFQ47224599-419FE76E-B08E-4874-BF5D-E8E6D03A85B0Q47241038-9EAA57BD-787C-4D7E-8A3D-DBEEBF5CE559Q47258075-2E560DBB-2C95-4D20-BDA1-9658AA83C65FQ48258958-D57CCA12-AB8E-4E3F-AFA6-886B3FEEB338Q49622479-853F3A7A-598E-433E-A591-1B4D26D68F54Q49939100-44AB8B93-1831-4844-9F75-FE848860C81FQ55129735-74943BBB-3B11-4048-8977-6243ABE249A7
P2860
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@ast
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@en
type
label
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@ast
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@en
prefLabel
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@ast
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@en
P2093
P2860
P1476
In vivo and in vitro pharmacological studies of methoxycarbonyl-carboetomidate.
@en
P2093
Douglas E Raines
Elizabeth W Kelly
Ervin Pejo
Gregory D Cuny
Jifeng Liu
Joseph F Cotten
Joydev K Laha
Xiang Jie Lin
P2860
P304
P356
10.1213/ANE.0B013E3182320559
P407
P577
2011-09-29T00:00:00Z